tranexamic acid has been researched along with Acute Chest Syndrome in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Acute Chest Syndrome: Respiratory syndrome characterized by the appearance of a new pulmonary infiltrate on chest x-ray, accompanied by symptoms of fever, cough, chest pain, tachypnea, or DYSPNEA, often seen in patients with SICKLE CELL ANEMIA. Multiple factors (e.g., infection, and pulmonary FAT EMBOLISM) may contribute to the development of the syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patil, V | 1 |
| Ratnayake, G | 1 |
| Fastovets, G | 1 |
1 review available for tranexamic acid and Acute Chest Syndrome
| Article | Year |
|---|---|
Clinical 'pearls' of maternal critical care Part 2: sickle-cell disease in pregnancy.
Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Antifibrinolytic Agents; Blood Transfusion; Critical Care | 2017 |